Skip to main content
. 2019 Oct 29;19:240. doi: 10.1186/s12872-019-1187-z

Fig. 2.

Fig. 2

Associations of a PCSK9 gene-centric score with ischemic and non-ischemic cardiovascular endpoints. Footnote: Effect estimates are presented as odds ratios (OR), with 95% confidence interval (CI) scaled to a 1 mmol/L lower LDL-C (mmol/L). Results are pooled using a fixed effect model. The size of the squares are proportional to the inverse of the variance